Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AstraZeneca AB (2)

02 9Astrazeneca Ab

03 2Astrazeneca Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi 50 mg/ml

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 120mg/2.4ml

Packaging :

Approval Date : 27-05-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

02

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi 50 mg/ml

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength :

Packaging :

Approval Date : 27-05-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

03

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

04

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 03-11-2020

Application Number : 1181322001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

06

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 03-11-2020

Application Number : 1181322002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

07

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 31-10-2018

Application Number : 1181322002

Regulatory Info : Authorized

Registration Country : Spain

blank

08

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 31-10-2018

Application Number : 1181322001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date : 21-09-2018

Application Number : 28106011517

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

euroPLX 90 Lisbon
Not Confirmed
arrow
arrow
euroPLX 90 Lisbon
Not Confirmed

Durvalumab

Brand Name : Imfinzi

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 50mg/ml

Packaging :

Approval Date : 21-09-2018

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank